Clinical Trial Update: A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating subcutaneous administration of purified human antibodies in patients with multifocal motor neuropathy has completed, and results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multifocal Motor Neuropathy

Drugs mentioned

• Purified Human Antibodies

Snippet

Sponsor: CSL Behring | Conditions: Multifocal Motor Neuropathy (MMN) | Phase 2 | Status: COMPLETED | Results posted: 2013-08-01